FDA Drug Recalls

Recalls / Class II

Class IID-0626-2017

Product

Ventolin HFA (albuterol sulfate) Inhalation Aerosol, 90 mcg per actuation, 200 Metered Inhalations, Net Wt. 18 g inhalers, Rx only, GlaxoSmithKline, Research Triangle Park, NC 22709, NDC 0173-0682-20.

Brand name
Ventolin
Generic name
Albuterol Sulfate
Active ingredient
Albuterol Sulfate
Route
Respiratory (inhalation)
NDC
0173-0682
FDA application
NDA020983
Affected lot / code info
Lot #: 6ZP9848, Exp 03/18; 6ZP0003, 6ZP9944, Exp 04/18.

Why it was recalled

Defective Delivery System: Elevated number of units with out of specification results for leak rate.

Recalling firm

Firm
GlaxoSmithKline, LLC
Manufacturer
GlaxoSmithKline LLC
Notification channel
Telephone
Type
Voluntary: Firm initiated
Address
1011 N Arendell Ave, N/A, Zebulon, North Carolina 27597-2309

Distribution

Quantity
593,088 inhalers
Distribution pattern
Nationwide in the USA and Puerto Rico

Timeline

Recall initiated
2017-03-22
FDA classified
2017-03-31
Posted by FDA
2017-04-12
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0626-2017. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Ventolin · FDA Drug Recalls